Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.

Diabetes Care · 2014 · PMC3994929 · PMID 24595631

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Notably, time-varying change in HbA 1c is not a significant predictor for those assigned to IS therapy, although it was highly significant for those assigned to IP therapy ( Supplementary Table 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.